Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2002
10/10/2002WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078602A2 Transdermal delivery of pergolide
10/10/2002WO2002062795A9 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/10/2002WO2001078780A1 Preventives/remedies for alzheimer's disease
10/10/2002WO2001049678A9 Substituted phenyl-piperazine derivatives, their preparation and use
10/10/2002US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002US20020147340 5-arylsulfonyl-imidazo[1',2':1,6]pyrido[2,3-b]pyrazine-6-amines and related compounds
10/10/2002US20020147334 Vitronectin Receptor Antagonists
10/10/2002US20020147210 Methods for delaying recurrence of herpes virus symptoms
10/10/2002US20020147209 Cycloalkano-indole and -azaindole derivatives
10/10/2002US20020147205 Heterocyclic compounds
10/10/2002US20020147199 Process for the treatment of erectile dysfunction and product therefor
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147194 Psychological disorders; antiserotonin agents; headache therapy
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147188 Protease inhibitors
10/10/2002DE10117183A1 Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel Use of substituted imidazo [1,2-a] -pyridinverbindungen as medicaments
10/10/2002DE10116303A1 Preparation of N-bridged heterobicyclic compounds, e.g. imidazolpyridine or triazolophthalazine compound, comprises oxidizing aldimine or hydrazone derivatives of N-heterocyclic compounds with copper(II) ions
10/10/2002CA2443128A1 Transdermal delivery of pergolide
10/10/2002CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002CA2442111A1 Europium compounds and ink compositions containing the same
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002CA2406832A1 Preventives/remedies for alzheimer's disease
10/09/2002EP1247804A1 Pyrimidine-thioalkyl and alkylether compounds
10/09/2002EP1247803A2 Indolinone compounds suitable for modulation of protein kinases
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246829A1 Novel heterocycles
10/09/2002EP1246819A1 A method for the preparation of substituted benzene derivatives
10/09/2002EP1246816A1 Substituted phenyl-piperazine derivatives, their preparation and use
10/09/2002EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1133495B1 Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid
10/09/2002EP0853477B1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
10/09/2002CN1373762A Phenanthroline-7-one derivs. and their therapeutic applications
10/09/2002CN1373761A Phenanthroline-7-one derivs. and their therapeutic uses
10/09/2002CN1373139A Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof
10/09/2002CN1373130A Process for preparing indolizine
10/09/2002CN1092196C Z-azabicyclo [2.2.1] heptane derivs., preparation and application thereof
10/09/2002CN1092195C N-([1,2,4]triazoloazinyl]-benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
10/09/2002CN1092193C Prolylendopeptidase inhibitors
10/09/2002CN1092022C Microbicides
10/08/2002US6462053 Neuropeptide y receptor antagonists; cardiovascular and central nervous system disorders and metabolic diseases; hypertension, nephropathy, heart disease, vasospasm, arteriosclerosis
10/08/2002US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002US6462044 Therapy for sexual disorders
10/08/2002US6462040 Microbiocides; bacteriocides; antiprotozoa agents; quinolone antibiotics; side effect reduction; antibiotic-resistant bacteria including staphyloccocus; veterinary medicine
10/08/2002US6462038 Such as 1,2,3,6-tetrahydro-1-methyl-9-(trifluoromethyl)-7h-(1,4)oxazino(3,2 -g)quinolin-7-one; nonsteroidal, high affinity and specificity antagonists and agonists or partial agonists, i.e. partial and/or tissue specific activators
10/08/2002US6461747 Materials for light emitting devices good in light emitting characteristics, excellent in stability in repeated use thereof, and excellent in color purity
10/08/2002US6461538 Production process for indolizine compounds and their use in organic light-emitting devices
10/08/2002CA2196769C Benzimidazole derivatives having dopaminergic activity
10/08/2002CA2095361C Optical isomers of 7-¬3-(1,1-dialkylmethyl-1-amino)-1-pyrrolidinyl|-quinolones and naphthyridones as antibacterial agents
10/08/2002CA2084489C Crystalline fumaric acid salts of 9,9-alkylene-3, 7-diazabicyclononane compounds and pharmaceutical compositions containing them
10/06/2002WO2003088897A2 Fab i inhibitors
10/06/2002CA2444597A1 Fab i inhibitors
10/03/2002WO2002076988A2 Tert. alkylphenoxy substituted polycyclic compounds
10/03/2002WO2002076985A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
10/03/2002WO2002076984A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
10/03/2002WO2002076982A2 Non-nucleoside reverse transcriptase inhibitors
10/03/2002WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002WO2002076973A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
10/03/2002WO2002076954A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
10/03/2002WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002WO2002076939A2 Cysteine protease inhibitors
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076396A2 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
10/03/2002WO2002076395A2 Agents and methods for treatment of cancer
10/03/2002WO2002062794A3 Compounds
10/03/2002WO2001085095A3 Chiral fluoroquinolizinone arginine salt forms
10/03/2002WO2001023385A9 Novel tropane analogs
10/03/2002WO2001019800A9 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/03/2002WO2000034265A3 Quinoline-indole antimicrobial agents
10/03/2002US20020143185 Nitrosation process
10/03/2002US20020143184 In crop protection and in the protection of materials
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143035 Hydantoin compounds useful as anti-inflammatory agents
10/03/2002US20020143034 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/03/2002US20020143029 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
10/03/2002US20020143025 For preventing free radical-mediated cellular damage or disruption; as oxidation inhibitors as additives to fuels, lubricants, rubber, polymers, chemicals, solvents and foodstuffs
10/03/2002US20020143024 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/03/2002US20020143018 For therapy of animals infected with parasites that cause abortigenic or neurologic diseases, for therapy of parasitic protozoa such as coccidia that cause abortigenic or neurologic diseases of mammals
10/03/2002US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002US20020143010 Compounds for treating fibromyalgia and chronic fatigue syndrome
10/03/2002US20020143008 CRF receptor antagonists and methods relating thereto
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/03/2002CA2441394A1 Agents and methods for treatment of cancer
10/02/2002EP1244679A1 Purine derivatives
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244666A1 Imidazopyrimidinyl and imidazopyridinyl derivatives
10/02/2002EP1244665A1 Triazatrinaphthyrins and the use thereof
10/02/2002EP1244664A1 Compounds and methods for the treatment of pain
10/02/2002EP1244663A1 Compounds and methods for the treatment of pain
10/02/2002EP1244662A1 Compound and method for the treatment of pain
10/02/2002EP1244661A1 Compounds and methods for the treatment of pain
10/02/2002EP1244660A1 Methods and compositions for the treatment of pain
10/02/2002EP1244659A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors
10/02/2002EP1244658A2 Azolyl-alkyl azole derivatives, a method for their production and their use as pesticides